Search Results - "Pasma, H R"

Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial by Wouters, E F M, Postma, D S, Fokkens, B, Hop, W C J, Prins, J, Kuipers, A F, Pasma, H R, Hensing, C A J, Creutzberg, E C

“…Background: Guidelines recommend inhaled corticosteroids (ICS) as maintenance treatment for patients with chronic obstructive pulmonary disease (COPD) with a…”
Get full text

Predictors of Obstructive Sleep Apnea-Hypopnea Treatment Outcome by Hoekema, A., Doff, M.H.J., de Bont, L.G.M., van der Hoeven, J.H., Wijkstra, P.J., Pasma, H.R., Stegenga, B.

“…Oral appliance therapy is an alternative to continuous positive airway pressure (CPAP) for treating the obstructive sleep apnea-hypopnea syndrome. However, the…”
Get full text

Effects of 2 weeks of treatment with fluticasone propionate 100 mcg b.d. by comparison with zafirlukast 20 mg b.d. on bronchial hyper-responsiveness in patients with mild to moderate asthma by WESTBROEK, J, PASMA, H.R

“…This study was designed to compare the effects of low-dose inhaled fluticasone propionate (100 mcg twice daily) with those of the leukotriene antagonist,…”
Get full text

Pneumocystis carinii pneumonia associated with low dose methotrexate treatment for rheumatoid arthritis by Stenger, A A, Houtman, P M, Bruyn, G A, Eggink, H F, Pasma, H R

“…Since 1983 there have been several reports on Pneumocystis carinii pneumonia (PCP), complicating low dose methotrexate (MTX) therapy for rheumatoid arthritis…”
Get more information

Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium by Vincken, W, van Noord, J.A, Greefhorst, A.P.M, Bantje, Th.A, Kesten, S, Korducki, L, Cornelissen, P.J.G

“…Tiotropium, a novel once-daily inhaled anticholinergic, has been shown to improve lung function over a 24-h period. In order to extend these findings,…”
Get full text

Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial by Wouters, E F M, Postma, D S, Fokkens, B, Hop, W C, Prins, J, Kuipers, A F, Pasma, H R, Hensing, C A J, Creutzberg, E C

Get full text